Literature DB >> 18728524

Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.

Antonella Tosco1, Maria Maglio, Francesco Paparo, Luciano Rapacciuolo, Anna Sannino, Erasmo Miele, Maria Vittoria Barone, Renata Auricchio, Riccardo Troncone.   

Abstract

OBJECTIVES: Anti-tissue transglutaminase (anti-TG2) immunoglobulin A (IgA) autoantibodies are detectable in the serum of most patients with untreated celiac disease (CD). Their deposits in the intestine of patients with CD with severe enteropathy are considered specific for this condition. The histological spectrum of CD includes cases with normal villous architecture. The aim of this study was to look for anti-TG2 IgA deposits in the intestine of children with normal villous architecture and to relate them with other markers of gluten sensitivity. PATIENTS AND METHODS: A total of 57 children with normal duodenal villous architecture and markers of gluten sensitivity were considered. Of those, 39 showed positive serum anti-endomysium antibodies and/or high levels of anti-TG2 antibodies (group 1), and 18 were seronegative with only a greater density of gammadelta intraepithelial lymphocytes (group 2). Thirty-four children with no markers of gluten sensitivity and a normal mucosa represented the control group (group 3). The duodenal sections of all patients were investigated for deposited anti-TG2 IgA by double immunofluorescence. Human lymphocyte antigen molecular typing was performed.
RESULTS: In group 1 and in group 2, 33 of 39 children (85%) and 12 of 18 children (66%) showed subepithelial anti-TG2 IgA intestinal deposits, respectively. Only in 3 of 34 (8.8%) children with no markers of gluten sensitivity were anti-TG2 IgA deposits noted.
CONCLUSIONS: A subgroup of children with no serum CD-associated autoantibodies, but greater density of gammadelta intraepithelial lymphocytes, shows a clear anti-TG2 IgA deposition in the duodenal mucosa. These children must be investigated further for possible gluten sensitivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728524     DOI: 10.1097/MPG.0b013e3181677067

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  25 in total

1.  Letter: Celiac Disease Presenting After a Single Anastomosis Duodeno-Ileal Bypass and Sleeve Gastrectomy.

Authors:  Amelie Therrien; Marie-Pierre Renaud; Lilia-Maria Sanchez; Louise D'Aoust; Michel Lemoyne
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

2.  Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.

Authors:  A Tosco; R Aitoro; R Auricchio; D Ponticelli; E Miele; F Paparo; L Greco; R Troncone; M Maglio
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

3.  Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.

Authors:  A Tosco; R Auricchio; R Aitoro; D Ponticelli; M Primario; E Miele; V Rotondi Aufiero; V Discepolo; L Greco; R Troncone; M Maglio
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

4.  Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.

Authors:  Lucia Montenegro; Domenico Piscitelli; Floriana Giorgio; Claudia Covelli; Maria Grazia Fiore; Giuseppe Losurdo; Andrea Iannone; Enzo Ierardi; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  Intestinal anti-tissue transglutaminase IgA deposits as a complementary method for the diagnostic evaluation of celiac disease in patients with low-grade histological lesions.

Authors:  María Roca; Ester Donat; Etna Masip; Verónica Ballester; Isabel Gómez; Mercedes SanFelix; David Ramos; Joaquim Calvo-Lerma; Lola Giner-Pérez; Miguel Bolonio; Begoña Polo; Carmen Ribes-Koninckx
Journal:  Clin Exp Immunol       Date:  2022-05-12       Impact factor: 4.330

6.  Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.

Authors:  M Borrelli; M Maglio; I R Korponay-Szabó; V Vass; M L Mearin; C Meijer; H Niv-Drori; C Ribes-Koninckx; M Roca; R Shamir; R Troncone; R Auricchio
Journal:  Clin Exp Immunol       Date:  2017-12-01       Impact factor: 4.330

Review 7.  Celiac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

8.  High density of intraepithelial gammadelta lymphocytes and deposits of immunoglobulin (Ig)M anti-tissue transglutaminase antibodies in the jejunum of coeliac patients with IgA deficiency.

Authors:  M Borrelli; M Maglio; M Agnese; F Paparo; S Gentile; B Colicchio; A Tosco; R Auricchio; R Troncone
Journal:  Clin Exp Immunol       Date:  2009-12-21       Impact factor: 4.330

9.  Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.

Authors:  Mariantonia Maglio; Fiorella Florian; Monica Vecchiet; Renata Auricchio; Francesco Paparo; Raffaella Spadaro; Delia Zanzi; Luciano Rapacciuolo; Adriana Franzese; Daniele Sblattero; Roberto Marzari; Riccardo Troncone
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  The intestinal B-cell response in celiac disease.

Authors:  Luka Mesin; Ludvig M Sollid; Roberto Di Niro
Journal:  Front Immunol       Date:  2012-10-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.